Oral cladribine and fingolimod for relapsing multiple sclerosis.
Mann
Howard
H
D017338:Cladribine / Q000627:therapeutic use; D032984:Ethics, Research; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007258:Informed Consent; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D010919:Placebos / Q000627:therapeutic use; D011409:Propylene Glycols / Q000627:therapeutic use; D012107:Research Design; D013110:Sphingosine / Q000031:analogs & derivatives / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D010919:Placebos; D011409:Propylene Glycols; D017338:Cladribine; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine